{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:06:45Z","timestamp":1787666805256,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771947"],"award-info":[{"award-number":["81771947"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.cbi.2023.110343","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T07:18:02Z","timestamp":1672989482000},"page":"110343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["PI3K \u03b4 inhibitor PI-3065 induces apoptosis in hepatocellular carcinoma cells by targeting survivin"],"prefix":"10.1016","volume":"371","author":[{"given":"Yuze","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaiming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9815-6630","authenticated-orcid":false,"given":"Ying","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2023.110343_bib1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 1","key":"10.1016\/j.cbi.2023.110343_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.31288","article-title":"Epidemiology of hepatocellular carcinoma","volume":"73","author":"McGlynn","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2023.110343_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14112798","article-title":"Emerging therapies for hepatocellular carcinoma (HCC)","volume":"14","author":"Chakraborty","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.cbi.2023.110343_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40164-018-0109-6","article-title":"Emerging therapies in advanced hepatocellular carcinoma","volume":"7","author":"Medavaram","year":"2018","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.cbi.2023.110343_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222313051","article-title":"Limitations and possibilities of transarterial chemotherapeutic treatment of hepatocellular carcinoma","volume":"22","author":"Ebeling Barbier","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2023.110343_bib6","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2023.110343_bib7","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jhep.2021.07.004","article-title":"Systemic treatment of hepatocellular carcinoma: an EASL position paper","volume":"75","author":"Bruix","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2023.110343_bib8","volume":"vol. 14","author":"Falette Puisieux","year":"2022"},{"key":"10.1016\/j.cbi.2023.110343_bib9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ceb.2017.02.007","article-title":"PI3K signaling in cancer: beyond AKT","volume":"45","author":"Lien","year":"2017","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.cbi.2023.110343_bib10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12943-019-0954-x","article-title":"Targeting PI3K in cancer: mechanisms and advances in clinical trials","volume":"18","author":"Yang","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cbi.2023.110343_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9111639","article-title":"Targeting the PI3K\/Akt\/mTOR pathway in hepatocellular carcinoma","volume":"9","author":"Sun","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.cbi.2023.110343_bib12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s13046-019-1455-x","article-title":"Interleukin-8 promotes integrin beta3 upregulation and cell invasion through PI3K\/Akt pathway in hepatocellular carcinoma","volume":"38","author":"Sun","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cbi.2023.110343_bib13","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.biopha.2018.04.072","article-title":"Inhibition of PI3K\/Akt\/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells","volume":"103","author":"Yang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2023.110343_bib14","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1111\/cas.13598","article-title":"PRMT9 promotes hepatocellular carcinoma invasion and metastasis via activating PI3K\/Akt\/GSK-3beta\/Snail signaling","volume":"109","author":"Jiang","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.cbi.2023.110343_bib15","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nature13444","article-title":"Inactivation of PI(3)K p110delta breaks regulatory T-cell-mediated immune tolerance to cancer","volume":"510","author":"Ali","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2023.110343_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000693","article-title":"Enhanced antitumor immunity through sequential targeting of PI3Kdelta and LAG3","volume":"8","author":"Lauder","year":"2020","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.cbi.2023.110343_bib17","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1039\/D0FO02243H","article-title":"Foeniculum vulgare seed extract exerts anti-cancer effects on hepatocellular carcinoma","volume":"12","author":"Ke","year":"2021","journal-title":"Food Funct."},{"key":"10.1016\/j.cbi.2023.110343_bib18","first-page":"582","article-title":"Increasing survival in HCV-related hepatocellular carcinoma","volume":"16","author":"Ray","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cbi.2023.110343_bib19","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.jid.2016.11.020","article-title":"Research techniques made simple: analysis of collective cell migration using the wound healing assay","volume":"137","author":"Grada","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cbi.2023.110343_bib20","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.trecan.2017.10.006","article-title":"Mitochondria, bioenergetics and apoptosis in cancer","volume":"3","author":"Burke","year":"2017","journal-title":"Trends Cancer"},{"key":"10.1016\/j.cbi.2023.110343_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111213","article-title":"Foeniculum vulgare seed extract induces apoptosis in lung cancer cells partly through the down-regulation of Bcl-2","volume":"135","author":"Ke","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2023.110343_bib22","doi-asserted-by":"crossref","first-page":"6633","DOI":"10.2147\/IJN.S140526","article-title":"The mechanisms of graphene-based materials-induced programmed cell death: a review of apoptosis, autophagy, and programmed necrosis","volume":"12","author":"Ou","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.cbi.2023.110343_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114073","article-title":"Aidi injection induces apoptosis of hepatocellular carcinoma cells through the mitochondrial pathway","volume":"274","author":"Lan","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.cbi.2023.110343_bib24","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.bbamcr.2010.08.002","article-title":"Apoptogenic factors released from mitochondria","volume":"1813","author":"Vaux","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2023.110343_bib25","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/med.21547","article-title":"Therapeutic strategies involving survivin inhibition in cancer","volume":"39","author":"Martinez-Garcia","year":"2019","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.cbi.2023.110343_bib26","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1080\/14712598.2021.1918672","article-title":"Survivin as a biological biomarker for diagnosis and therapy","volume":"21","author":"Li","year":"2021","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.cbi.2023.110343_bib27","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2023.110343_bib28","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(16)32453-9","article-title":"Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"389","author":"Bruix","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2023.110343_bib29","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jhep.2019.10.021","article-title":"Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma","volume":"72","author":"Sangro","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2023.110343_bib30","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/s41419-018-0960-8","article-title":"Idelalisib promotes Bim-dependent apoptosis through AKT\/FoxO3a in hepatocellular carcinoma","volume":"9","author":"Yue","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cbi.2023.110343_bib31","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00280-019-03918-y","article-title":"Preclinical efficacy of a novel dual PI3K\/mTOR inhibitor, CMG002, alone and in combination with sorafenib in hepatocellular carcinoma","volume":"84","author":"Kim","year":"2019","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.cbi.2023.110343_bib32","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s10495-007-0746-4","article-title":"Embedded together: the life and death consequences of interaction of the Bcl-2 family with membranes","volume":"12","author":"Leber","year":"2007","journal-title":"Apoptosis"},{"key":"10.1016\/j.cbi.2023.110343_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2021.183716","article-title":"Apoptosis regulation at the mitochondria membrane level","volume":"1863","author":"Dadsena","year":"2021","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.cbi.2023.110343_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109500","article-title":"Lysionotin induces apoptosis of hepatocellular carcinoma cells via caspase-3 mediated mitochondrial pathway","volume":"344","author":"Yang","year":"2021","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2023.110343_bib35","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s10495-022-01728-x","article-title":"p53 m(6)A modulation sensitizes hepatocellular carcinoma to apatinib through apoptosis","volume":"27","author":"Ke","year":"2022","journal-title":"Apoptosis"},{"key":"10.1016\/j.cbi.2023.110343_bib36","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.lfs.2018.08.025","article-title":"Luteolin induces caspase-dependent apoptosis via inhibiting the AKT\/osteopontin pathway in human hepatocellular carcinoma SK-Hep-1 cells","volume":"209","author":"Im","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.cbi.2023.110343_bib37","first-page":"9","article-title":"Functional compartmentalization of HSP60-survivin interaction between mitochondria and cytosol in cancer cells","author":"Huang","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.cbi.2023.110343_bib38","first-page":"11","article-title":"Grape seed proanthocyanidins induce autophagy and modulate survivin in HepG2 cells and inhibit xenograft tumor growth in vivo","author":"Wang","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.cbi.2023.110343_bib39","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s13402-021-00595-z","article-title":"YAP promotes sorafenib resistance in hepatocellular carcinoma by upregulating survivin","volume":"44","author":"Sun","year":"2021","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.cbi.2023.110343_bib40","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ejmech.2017.02.027","article-title":"Novel multi-substituted benzyl acridone derivatives as survivin inhibitors for hepatocellular carcinoma treatment","volume":"129","author":"Zhang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2023.110343_bib41","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.canlet.2018.03.044","article-title":"Survivin-targeted drug screening platform identifies a matrine derivative WM-127 as a potential therapeutics against hepatocellular carcinoma","volume":"425","author":"Yin","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cbi.2023.110343_bib42","doi-asserted-by":"crossref","first-page":"314","DOI":"10.7150\/jca.13332","article-title":"Survivin and tumorigenesis: molecular mechanisms and therapeutic strategies","volume":"7","author":"Chen","year":"2016","journal-title":"J. Cancer"},{"key":"10.1016\/j.cbi.2023.110343_bib43","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1476-4598-13-2","article-title":"Vertical blockade of the IGFR- PI3K\/Akt\/mTOR pathway for the treatment of hepatocellular carcinoma: the role of survivin","volume":"13","author":"Ou","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cbi.2023.110343_bib44","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.biopha.2018.01.131","article-title":"MicroRNA-542-3p functions as a tumor suppressor via directly targeting survivin in hepatocellular carcinoma","volume":"99","author":"Wang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2023.110343_bib45","doi-asserted-by":"crossref","first-page":"13822","DOI":"10.18632\/aging.202976","article-title":"Development and validation of epithelial mesenchymal transition-related prognostic model for hepatocellular carcinoma","volume":"13","author":"Wang","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.cbi.2023.110343_bib46","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.tcb.2020.07.003","article-title":"EMT, MET, plasticity, and tumor metastasis","volume":"30","author":"Bakir","year":"2020","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.cbi.2023.110343_bib47","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1245\/s10434-011-1692-5","article-title":"Survivin-mediated cancer cell migration through GRP78 and epithelial-mesenchymal transition (EMT) marker expression in Mahlavu cells","volume":"19","author":"Tai","year":"2012","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.cbi.2023.110343_bib48","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijbiomac.2019.06.189","article-title":"Basil polysaccharide inhibits hypoxia-induced hepatocellular carcinoma metastasis and progression through suppression of HIF-1alpha-mediated epithelial-mesenchymal transition","volume":"137","author":"Feng","year":"2019","journal-title":"Int. J. Biol. Macromol."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279723000108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279723000108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T20:35:47Z","timestamp":1736368547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279723000108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":48,"alternative-id":["S0009279723000108"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2023.110343","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PI3K \u03b4 inhibitor PI-3065 induces apoptosis in hepatocellular carcinoma cells by targeting survivin","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2023.110343","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110343"}}